🔴 Lantern Pharma is trading 6.6% down; no clear company-specific catalyst identified

Lantern Pharma is trading at $0.60, down 6.62%, with no clear company-specific catalyst identified.

• The company’s investor-relations page listed October 8 as its latest release; no clear Lantern Pharma-specific announcement surfaced for October 23, 2026.
• Reuters reported lingering concern about AI spending and Brent crude above $114 on October 23, while the tech selloff had eased. Available evidence does not establish that these conditions caused the decline.